Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

ProQR Therapeutics N.V. buy blaugold

ProQR Therapeutics N.V.
Start price
€1.67
21.01.24 / 50%
Target price
-
21.01.25
Performance (%)
18.80%
End price
€1.98
03.02.24
Summary
This prediction ended on 03.02.24 with a price of €1.98. The prediction had a final performance of 18.80%. blaugold has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
ProQR Therapeutics N.V. -1.850% -1.850%
iShares Core DAX® 3.178% 0.980%
iShares Nasdaq 100 2.972% 0.925%
iShares Nikkei 225® 0.545% -4.556%
iShares S&P 500 2.367% 0.833%

According to blaugold what are the pros and cons of ProQR Therapeutics N.V. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by blaugold for this prediction

In the thread ProQR Therapeutics N.V. diskutieren

Buy ProQR Therapeutics N.V.

blaugold 
0
Report Share
21.01.24 Buy 18.80%
In the thread Trading ProQR Therapeutics N.V.
Prediction Buy
Perf. (%) 18.80%
Target price
Change
Ends at 21.01.25

Buy beendet

blaugold 
0
Report Share
03.02.24

Stopped prediction by blaugold for ProQR Therapeutics N.V.

buy
ProQR Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.82
30.03.23
-
30.03.24
-2.03%
14.05.23

Could be worthwhile Investment >10% per year
blaugold 
30.03.23 50%